Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 207325
Company: GLAND
Company: GLAND
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | AP | No | Yes |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | AP | No | Yes |
| OXALIPLATIN | OXALIPLATIN | 200MG/40ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 02/10/2017 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/11/2023 | SUPPL-9 | Labeling-Package Insert |
Label is not available on this site. |
||
| 12/15/2021 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
OXALIPLATIN
INJECTABLE;INTRAVENOUS; 50MG/10ML (5MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207474 | ACCORD HLTHCARE |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078811 | FRESENIUS KABI USA |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207325 | GLAND |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217925 | HETERO LABS LTD VI |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078813 | HOSPIRA WORLDWIDE |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217348 | MEITHEAL |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 091358 | MYLAN LABS LTD |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 204368 | QILU PHARM HAINAN |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078817 | SANDOZ |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 219765 | SHANDONG |
INJECTABLE;INTRAVENOUS; 100MG/20ML (5MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207474 | ACCORD HLTHCARE |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078811 | FRESENIUS KABI USA |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207325 | GLAND |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217925 | HETERO LABS LTD VI |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078813 | HOSPIRA WORLDWIDE |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217348 | MEITHEAL |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 091358 | MYLAN LABS LTD |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 204368 | QILU PHARM HAINAN |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078817 | SANDOZ |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 219765 | SHANDONG |